LATEST NEWS
EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital
EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel
EXACT Therapeutics announces first half 2023 interim results
EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer